Articles From: - Comverse Inaugurates New APAC Center of Excellence in India to - UPDATE: 4 ways Gilead's earnings will impact every American


WAKEFIELD, Mass., July 23, 2014 (GLOBE NEWSWIRE) -- Comverse (Nasdaq:CNSI) , a global leader in digital services and monetization solutions, announced the inauguration of its new state-of-the-art Comverse Center of Excellence (CCoE) in Gurgaon, India.
Sign-up for - Comverse Inaugurates New APAC Center of Excellence in India investment picks
Janus Capital Group Inc. (“JCG”) (NYSE: JNS) today reported second quarter net income of $36.3 million, or $0.19 per diluted share, compared with first quarter 2014 net income of $30.5 million, or $0.16 per diluted share, and net income of $15.8 million, or $0.08 per diluted share, in the second quarter 2013.
Sign-up for - Janus Capital Group Inc. Announces Second Quarter 2014 Results investment picks
BETHESDA, Maryland and ABINGDON, Oxfordshire, July 23, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP) , a global biopharmaceutical company, today announced that the United Kingdom's National Institute of Health and Care Excellence (NICE) has published the technology appraisal guidance recommending the use of AMITIZA ® (lubiprostone) in the treatment of chronic idiopathic constipation (CIC) and associated symptoms in adults who have failed laxatives.
Sign-up for - Sucampo Announces Publication of NICE Recommendation for AMITIZA(R) (Lubiprostone) investment picks
2014/7/23
By Quentin Fottrell, MarketWatch Deactivating your Facebook account is a personal choice.
Sign-up for 2014/7/23 - UPDATE: Facebook's 'cult' is a win for shareholders investment picks
2014/7/23
The board of directors of Praxair, Inc. (NYSE:PX) has declared a quarterly dividend of 65 cents per share, unchanged from the previous quarter.
Sign-up for 2014/7/23 - Praxair Declares Dividend in Third Quarter 2014 investment picks
2014/7/23
Most affordable Lumia available in August 2014.
Sign-up for 2014/7/23 - New Lumia 530 brings uncompromised smartphone performance under 100 euros investment picks
College interns from United Launch Alliance (ULA) and Ball Aerospace & Technologies Corp., K-12 students to launch the largest rocket in Colorado CENTENNIAL, Colo.
Sign-up for - Students to Launch the Future of Colorado Aerospace on Saturday, July 26 investment picks
2014/7/23
By Therese Poletti, MarketWatch SAN FRANCISCO (MarketWatch) -- Facebook Inc. said that its capital expenditures were up 40% in the first half of this year, and Wall Street did not bat an eye.
Sign-up for 2014/7/23 - Facebook investors OK with big spending investment picks
OSWEGO, N.Y., July 23, 2014 (GLOBE NEWSWIRE) -- Pathfinder Bancorp, Inc. ("Company"), the mid-tier holding company of Pathfinder Bank ("Bank"), (Nasdaq:PBHC) announced its results for the three and six-month periods ended June 30, 2014.
Sign-up for - Pathfinder Bancorp, Inc. Announces Second Quarter and Year to Date Earnings investment picks
Terex Corporation (NYSE:TEX) today announced income from continuing operations of $87.8 million, or $0.76 per share, for the second quarter of 2014.
Sign-up for - Terex Announces Second Quarter 2014 Results investment picks
2014/7/23
By Quentin Fottrell, MarketWatch Apple Inc. is dependent on the iPhone for more than half of its revenue.
Sign-up for 2014/7/23 - Why Apple may never have another product as successful as the iPhone investment picks
HOUSTON , July 23, 2014 /PRNewswire/ -- Oceaneering International, Inc. (NYSE: OII) announced today that its Board of Directors declared a regular quarterly dividend of $0.27 per common share.
Sign-up for - Oceaneering Declares Quarterly Dividend investment picks
2014/7/23
By Sue Chang, MarketWatch SAN FRANCISCO (MarketWatch)--Shares of Facebook Inc. rallied in Wednesday's after-hours trading as the social media company reported better-than-expected quarterly earnings.
Sign-up for 2014/7/23 - UPDATE: Facebook rallies in after hours as results top outlook investment picks
Today WashingtonFirst Bankshares Inc. (NASDAQ: WFBI) (the "Company"), the holding company for WashingtonFirst Bank (the "Bank"), reports unaudited consolidated net income to common shareholders for the three months ended June 30, 2014 of $2.4 million ($0.29 per diluted common share) compared to $1.5 million ($0.18 per diluted common share) for the three months ended June 30, 2013.
Sign-up for - WashingtonFirst Bankshares Inc. Reports Record Quarterly Earnings and Declares Stock Dividend investment picks
The Board of Directors of Energen Corporation (NYSE: EGN) today declared a quarterly cash dividend of 15 cents per share payable September 2, 2014, to shareholders of record on August 15, 2014.
Sign-up for - Energen Declares Quarterly Cash Dividend investment picks
Turbo-Tandem ® and Turbo Elite ® are indicated to treat peripheral ISR, the only on-label products in the industry COLORADO SPRINGS, Colo., July 23, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance of their peripheral atherectomy products, Turbo-Tandem ® and Turbo Elite ® , for the treatment of in-stent restenosis (ISR). The clearance prompts a new standard of care in ISR treatment with improved clinical outcomes.
Sign-up for - Spectranetics Announces FDA Clearance of Peripheral Laser Atherectomy Devices for In-Stent Restenosis investment picks
2014/7/23
Adira Energy Closes Private Placement Canada NewsWire TORONTO , July 23, 2014 /CNW/ - ADIRA ENERGY LTD.
Sign-up for 2014/7/23 - Adira Energy Closes Private Placement investment picks
Incyte Corporation (Nasdaq: INCY) today announced top-line results from RELIEF, a randomized, double-blind clinical trial designed to compare symptom improvement in 110 patients with polycythemia vera (PV) treated with ruxolitinib versus patients treated with hydroxyurea (HU). While positive trends were observed in favor of ruxolitinib, the trial did not achieve statistical significance for the primary endpoint as measured by the proportion of patients with ≥ 50% reduction in a defined cluster of symptoms that included tiredness, itching, muscle aches, night sweats and sweats while awake at week 16 compared to baseline.
Sign-up for - Incyte Announces Top-Line Results from RELIEF Trial of Ruxolitinib in Patients with Polycythemia Vera investment picks
Company also Extends Authorized Stock Repurchase Program PHILADELPHIA , July 23, 2014 /PRNewswire/ -- Destination Maternity Corporation (Nasdaq: DEST) , the world's leading maternity apparel retailer, today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.20 per share.
Sign-up for - Destination Maternity Declares Quarterly Cash Dividend investment picks
ATLANTA , July 23, 2014 /PRNewswire/ -- CatchMark Timber Trust, Inc. (NYSE: CTT) today announced the underwriters of its previously announced public offering of Class A common stock, which closed on July 11, 2014 , have exercised in full their option to purchase up to an additional 1,875,000 shares.
Sign-up for - Underwriters of CatchMark Public Offering Exercise in Full Option to Purchase Additional Shares investment picks
SCOTTSDALE, Ariz., July 23, 2014 (GLOBE NEWSWIRE) -- Kona Grill, Inc. (Nasdaq:KONA) , an American grill and sushi bar, will hold a conference call on Monday, August 4, 2014 at 4:30 p.m. Eastern time to discuss its financial results for the second quarter ended June 30, 2014.
Sign-up for - Kona Grill Sets Second Quarter 2014 Conference Call for Monday, August 4, 2014 at 4:30 p.m. ET investment picks
NEW ALBANY, Ohio, July 23, 2014 (GLOBE NEWSWIRE) -- Bob Evans Farms, Inc., (Nasdaq:BOBE) today sent to its stockholders a letter from Lead Independent Director Michael Gasser and Chairman and Chief Executive Officer Steve Davis outlining the strong qualifications of the Board's dynamic and open-minded nominees to the Board of Directors at the Company's 2014 Annual Meeting.
Sign-up for - Bob Evans Farms Details Strong Qualifications of Its Director Nominees in Letter to Stockholders investment picks
2014/7/23
AT&T Inc. ( NYSE:T ) today reported strong second-quarter wireless postpaid gains and record low postpaid churn driven by the growing popularity of AT&T Next and Mobile Share Value SM plans.
Sign-up for 2014/7/23 - Best-Ever Postpaid Churn Drives Strongest Postpaid Net Adds in Nearly Five Years and Continued U-verse Gains Highlight AT&T’s Second Quarter as Business Transformation Continues investment picks
BlackRock, Inc. (NYSE:BLK) today announced that its Board of Directors has declared a quarterly cash dividend of $1.93 per share of common stock, payable September 22, 2014 to shareholders of record at the close of business on September 2, 2014.
Sign-up for - BlackRock Declares Quarterly Dividend of $1.93 on Common Stock investment picks
Local Corporation (NASDAQ: LOCM), a leading local advertising technology company, today announced it will be a featured presenter at the Needham Interconnect Conference on Wednesday, August 6, at The Westin Grand Central Hotel, New York.
Sign-up for - Local Corporation to Present at the Needham Interconnect Conference investment picks
2014/7/23
NEW YORK and JAKARTA, Indonesia, July 23, 2014 (GLOBE NEWSWIRE) -- Vanguard Mining Corporation (Pink Sheets:VNMC) today announced that PT Raksasa Metal Agung, an Indonesian partner of the Company's, has reported highly favorable results from its recent survey of the prospective gold and copper mining area in Karang Tengah District, Wonogiri Regency, Central Java Province, Indonesia, with copper content of over 14%, silver at 17.50 ppm and gold 9.20 ppm.
Sign-up for 2014/7/23 - Vanguard Mining Corporation Reports Favorable Central Java Survey Results investment picks
NEW YORK , July 23, 2014 /PRNewswire/ -- Scholastic Corporation (NASDAQ: SCHL) is pleased to announce that its Board of Directors today declared a quarterly cash dividend of $0.15 per share on the Company's Class A and Common Stock for the first quarter of fiscal 2015.
Sign-up for - Scholastic Corporation Announces First Quarter Dividend investment picks
By Tim Mullaney Today's earnings report from Gilead Sciences will be closely watched on both Wall Street and Capitol Hill, where the argument about how much the world's second-most-valuable biotech company should charge for its new $84,000 hepatitis C drug Sovaldi is getting more and more heated.
Sign-up for - UPDATE: 4 ways Gilead's earnings will impact every American investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: - Comverse Inaugurates New APAC Center of Excellence in India to - UPDATE: 4 ways Gilead's earnings will impact every American
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices